Dark
Light
System
Institutional Investment Manager
ASYMMETRY CAPITAL MANAGEMENT, L.P.
ASYMMETRY CAPITAL MANAGEMENT, L.P. (CIK: 0001657134). Institutional holdings reported to the SEC.

Institutional Holdings (2016Q2)
Portfolio Summary: 19 holdings with a total value of $54,588,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 CENTENE CORP DEL 82,135 5,862,000 10.74%
2 JAZZ PHARMACEUTICALS PLC SHS USD 39,540 5,587,000 10.23%
3 LILLY ELI & CO 58,965 4,643,000 8.51%
4 BIO-RAD LABRATORIES 31,029 4,438,000 8.13%
5 TEVA PHARMACEUTICAL INDS LTD 83,502 4,194,000 7.68%
6 NEVRO CORP 50,633 3,735,000 6.84%
7 UNITEDHEALTH GROUP INC 23,648 3,339,000 6.12%
8 QUEST DIAGNOSTICS INC 34,843 2,837,000 5.20%
9 EDWARDS LIFESCIENCES CORP 28,270 2,819,000 5.16%
10 ALERE INC 63,905 2,664,000 4.88%
11 PTC THERAPEUTICS INC 306,650 2,153,000 3.94%
12 INCYTE 25,510 2,040,000 3.74%
13 IMPAX LABORATORIES INC 70,235 2,024,000 3.71%
14 IRONWOOD PHARMACEUTICALS 121,325 1,586,000 2.91%
15 AERIE PHARMACEUTICALS INC 84,026 1,479,000 2.71%
16 PACIRA BIOSCIENCES INC 41,707 1,407,000 2.58%
17 NEUROCRINE BIOSCIE COM USD0.001 30,671 1,394,000 2.55%
18 AMICUS THERAPEUTICS INC 229,626 1,254,000 2.30%
19 SYNERGY PHARMACEUTICALS DEL COM NEW 298,190 1,133,000 2.08%

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001657134-16-000006, filed 2016.08.05).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.